# Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin

> **NCT05135182** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 170 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** Furazolidone
- **DRUG:** Metronidazole

## Key facts

- **NCT ID:** NCT05135182
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-28
- **Primary completion:** 2022-10
- **Final completion:** 2022-12
- **Target enrollment:** 170 (ESTIMATED)
- **Last updated:** 2021-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05135182

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05135182, "Helicobacter Pylori Rescue Treatment in Patients Allergic to Penicillin". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05135182. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*